EMERALD MUTUAL FUND ADVISERS TRUST
Mutual FundPosition in PVLA — Palvella Therapeutics, Inc.
CIK 1352895
Leola, PA
Position in PVLA
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$19,843,218
+$6,652,755 QoQ
Shares Held
129,847
+22.7% QoQ
Ownership
0.901%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#26
of 197 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PVLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EMERALD MUTUAL FUND ADVISERS TRUST holds $391,799,835 across 21 Biotechnology names. PVLA ranks #9 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TVTX |
Travere Therapeutics, Inc.
|
1,032,024 | $58,629,283 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
464,902 | $40,423,228 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
1,031,378 | $39,914,328 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
401,271 | $35,624,839 | |
| 5 | MIRM |
Mirum Pharmaceuticals, Inc.
|
289,372 | $33,876,780 | |
| 6 | MANE |
Veradermics, Inc
|
209,924 | $25,808,056 | |
| 7 | CYTK |
Cytokinetics Inc
|
279,769 | $23,833,521 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
1,210,965 | $22,584,497 |
All Filings in PVLA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,843,218 | 129,847 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $13,190,463 | 105,820 | Shares | Sole | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||